# Mesalamine

NDC: 62135-714
Generic name: Mesalamine
Labeler / Manufacturer: Chartwell RX, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, DELAYED RELEASE
Routes: ORAL
Marketing started: 20230603

FDA application: ANDA217337

## Active ingredients

- MESALAMINE: 1.2 g/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"62135-714"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=62135-714
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9703f92d-1d15-4376-8b2b-51502c266012